tiprankstipranks
Medicenna Therapeutics Corp (MDNA)
NASDAQ:MDNA
Holding MDNA?
Track your performance easily

Medicenna Therapeutics Corp (MDNA) Stock Forecast & Price Target

154 Followers
See the Price Targets and Ratings of:

MDNA Analyst Ratings

Strong Buy
4Ratings
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Medicenna
Therapeutics Corp
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MDNA Stock 12 Month Forecast

Average Price Target

Based on 4 Wall Street analysts offering 12 month price targets for Medicenna Therapeutics Corp in the last 3 months. The average price target is $3.26 with a high forecast of $5.98 and a low forecast of $1.59. The average price target represents a change from the last price of .
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
Highest Price Target$5.98Average Price Target$3.26Lowest Price Target$1.59
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guggenheim
$1.46
Buy
Initiated
11/29/22
Guggenheim Initiates Coverage On Medicenna Therapeutics with Buy Rating, Announces Price Target of C$2

Best Analysts Covering Medicenna Therapeutics Corp

Which Analyst Should I Follow If I Want to Buy MDNA and Sell After:
1 Month
xxx
Success Rate
3/11 ratings generated profit
27%
Average Return
-6.99%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 27.27% of your transactions generating a profit, with an average return of -6.99% per trade.
3 Months
xxx
Success Rate
3/15 ratings generated profit
20%
Average Return
-23.85%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 20.00% of your transactions generating a profit, with an average return of -23.85% per trade.
1 Year
Swayampakula RamakanthH.C. Wainwright
Success Rate
0/15 ratings generated profit
0%
Average Return
-60.72%
reiterated a buy rating a year ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -60.72% per trade.
2 Years
xxx
Success Rate
0/11 ratings generated profit
0%
Average Return
-78.77%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -78.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDNA Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MDNA Financial Forecast

No data currently available

MDNA Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

MDNA Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

MDNA Stock Forecast FAQ

What is MDNA’s average 12-month price target, according to analysts?
Based on analyst ratings, Medicenna Therapeutics Corp’s 12-month average price target is $3.26.
    What is MDNA’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MDNA, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is MDNA a Buy, Sell or Hold?
        Medicenna Therapeutics Corp has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Medicenna Therapeutics Corp’s price target?
          The average price target for Medicenna Therapeutics Corp is $3.26. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $5.98 ,the lowest forecast is $1.59. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about Medicenna Therapeutics Corp?
            Medicenna Therapeutics Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
              How can I buy shares of MDNA?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis